Vericel Corporation (VCEL) by event type
VCEL moves most on analyst upgrades — a median of +0.52% at 30 minutes across 21 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the VCEL overview →
How VCEL reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 344 of 2,717 | 21 | +0.52% | 81% | -0.26% |
| Analyst downgrades 515 of 2,603 | 18 | +0.37% | 56% | +0.21% |
| Coverage initiations 1,555 of 2,283 | 10 | -0.13% | 50% | +1.22% |
| Rating reiterations 420 of 3,522 | 54 | +0.22% | 59% | +1.08% |
| Price-target raises 174 of 1,790 | 13 | +0.23% | 62% | +1.31% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how VCEL usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · VCEL overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ALLIQUA BIOMEDICAL (ALQA) | 407 | -0.11% | 43% |
| NeoGenomics, Inc. (NEO) | 406 | -0.22% | 44% |
| SPRING BANK PHARMACEUTICALS (SBPH) | 404 | 0.00% | 37% |
| AKCEA THERAPEUTICS (AKCA) | 401 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.